Top brokers name 3 ASX shares to sell today

The bears are saying investors shouldn't be buying these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three ASX shares that have just been given sell ratings by brokers are listed below. Here's why these brokers are bearish on them:

Model bear in front of falling line graph, cheap stocks, cheap ASX shares

Image source: Getty Images

Magellan Financial Group Ltd (ASX: MFG)

According to a note out of Goldman Sachs, its analysts have retained their sell rating and $47.97 price target on this fund manager's shares. This follows the launch of Magellan's FuturePay equity income product, which will pay a fixed distribution benchmarked to inflation. While the product may be appealing for advisors, Goldman doesn't believe it is for investors. As such, it isn't adjusting its earnings forecasts to account for its launch until it can better gauge demand. In light of this, and with its performance still skewing earnings risks to the downside, it has retained its sell rating. The Magellan share price is trading at $48.86 today.

Prime Media Group Limited (ASX: PRT)

A note out of Morgan Stanley reveals that its analysts have retained their underweight rating but lifted their price target on the regional television focused media company's shares to 9 cents. The broker believes that regional TV advertising is improving after the recent downturn. However, while this may be positive, Morgan Stanley continues to believe that its medium to long term earnings are under threat due to a structural decline in the regional advertising market. The Prime Media share price is trading at 23 cents this afternoon.

Virtus Health Ltd (ASX: VRT)

Another note out of Morgan Stanley reveals that its analysts have retained their underweight rating and $5.05 price target on this fertility treatment company's shares. The broker notes that IVF cycles are growing strongly versus both 2020 and 2019 levels and are expected to continue doing so during the second half. However, due to its stretched valuation, Morgan Stanley believes there are better options for investors in the industry. The Virtus Health share price is fetching $6.23 on Thursday.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Brambles, CBA, and Macquarie shares

Do analysts rate these shares as buys? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »